U040.F Pegasus Mercantile Inc.
- Market cap
- EUR 154K
- P/E
- -
- P/B
- 3.81x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jun 2026.
Is U040.F undervalued?
Graham numberThe Graham number of Pegasus Mercantile Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Pegasus Mercantile Inc. fundamental analysis
No fundamental analysis for Pegasus Mercantile Inc. yet.
Pegasus Mercantile Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Pegasus Mercantile Inc.
Pegasus Mercantile Inc. is an incubator, venture capital firm specializing in incubation, startup and early stage. The firm prefers to make growth investments. The firm seeks to invest in the public and private sectors that focus on preventative health, wellness issues, related consumer products, biotechnology, specific areas of pain, Psychedelic, depression, mental illness health and medicine sectors. By investing in pioneering techniques such as micro-dosing using organic …
Full company profilePegasus Mercantile Inc. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Pegasus Mercantile Inc. annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 0.00 | 0.00 | 25.7K | 58.7K | 36.9K | 0.00 |
| Gross Profit | -1.51K | -2.67K | 23.4K | 24.5K | -3.90K | -14.6K |
| Operating Income | -3.88M | -1.38M | -916K | -624K | -566K | -570K |
| EBITDA | - | -1.38M | -916K | -624K | -566K | -570K |
| Net Income | -3.58M | -1.37M | -456K | -546K | -381K | -570K |
| EPS | -0.80 | -0.18 | -0.05 | -0.05 | -0.03 | -0.04 |
| Balance Sheet | ||||||
| Total Assets | 25.6K | 298K | 431K | 434K | 218K | 85.4K |
| Total Liabilities | 543K | 746K | 703K | 882K | 874K | 1.17M |
| Shareholders' Equity | -517K | -449K | -272K | -448K | -656K | -1.08M |
| Cash & Short-term Investments | 25.6K | 0.00 | - | - | - | - |
| Cash Flow | ||||||
| Operating Cash Flow | -98.4K | -426K | -80.7K | -116K | -275K | -34.9K |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | -98.4K | -426K | -80.7K | -116K | -275K | -34.9K |
| Ratios | ||||||
| ROA | -13,984.4% | -459.6% | -105.7% | -125.8% | -174.8% | -667.7% |
| Net Profit Margin | - | - | -1,777.2% | -929.9% | -1,032.3% | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Pegasus Mercantile Inc. dividends
Pegasus Mercantile Inc. has not paid dividends in the last 5 fiscal years.
Last stock split: 1:5 on Jan 31, 2025.
Who owns Pegasus Mercantile Inc.
- Insiders 8.82%
- Institutions 0.00%
- Public & others 91.19%
- Shares outstanding 13.4M
- Free float 10.0M
Pegasus Mercantile Inc. company profile
- Company name
- Pegasus Mercantile Inc.
- Ticker
- U040.F
- ISIN
- CA70557Y2042
- Exchange
- Frankfurt Exchange
- Sector
- Financial Services
- Industry
- Credit Services
- Fiscal year end
- September
- Address
- 702 ? 595 Howe Street, Vancouver, BC, Canada, V6C 2E5
- Website
- xtacytherapeutics.com
About Pegasus Mercantile Inc.
Pegasus Mercantile Inc. is an incubator, venture capital firm specializing in incubation, startup and early stage. The firm prefers to make growth investments. The firm seeks to invest in the public and private sectors that focus on preventative health, wellness issues, related consumer products, biotechnology, specific areas of pain, Psychedelic, depression, mental illness health and medicine sectors. By investing in pioneering techniques such as micro-dosing using organic compounds and synthetic molecules, we are focusing on ground breaking research with the aim of providing superior wellness benefits with less side effects, better for peoples and the planet. The firm seeks to invest in Canada. The firm also provides debt financing facility. Pegasus Mercantile Inc. was incorporated in 1998 and is headquartered in Vancouver, Canada with an additional office in Vancouver, Canada.
Pegasus Mercantile Inc. management
7- Ms. Meris KottCEO & Director · born 1961
- Mr. Lindsey R. Perry Jr.CFO & Director · born 1954
- Dr. Robert KleinStrategic Medical Business Advisor
- Ms. Leah KincaidBusiness Advisor
- Dr. Sudhanshu Agarwal B.Sc.Chief Medical Advisor · born 1976
- Mr. Darryl Davies B.Sc.Business Advisor
- Ms. Shiry Eden M.B.A.Business Advisor